Sonnet BioTherapeutics Holdings, Inc. - Common Stock (SONN)
1.1671
-0.0029 (-0.25%)
NASDAQ · Last Trade: Jun 3rd, 9:34 PM EDT

Via Benzinga · May 28, 2025

Via Benzinga · May 28, 2025
Via Benzinga · April 24, 2025

Via Benzinga · December 9, 2024

Via Benzinga · November 6, 2024

Via Benzinga · November 6, 2024

Via Benzinga · November 6, 2024

Via Benzinga · October 28, 2024

Via Benzinga · October 28, 2024

Via Benzinga · October 17, 2024

Via Benzinga · September 26, 2024

Sonnet BioTherapeutics shares are trading lower by 15.5% Wednesday afternoon. The company announced a 1-for-8 reverse stock split.
Via Benzinga · September 25, 2024

Via Benzinga · August 16, 2024

SONN stock results show that Sonnet BioTherapeutics beat analyst estimates for earnings per share the third quarter of 2024.
Via InvestorPlace · August 14, 2024

Via Benzinga · June 21, 2024

Via Benzinga · June 20, 2024

Via Benzinga · June 20, 2024

Via Benzinga · June 20, 2024

SONN stock results show that Sonnet BioTherapeutics missed analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · May 15, 2024

Via Benzinga · February 14, 2024

Via Benzinga · February 13, 2024

Via Benzinga · November 28, 2023